Adipositas bei Frauen – Prävention in allen Lebensphasen

Frauen sind im Verlauf ihres Lebens einem unterschiedlich hohen Risiko für Übergewicht und Adipositas ausgesetzt. Dieser Artikel soll für Möglichkeiten der Prävention in besonders wichtigen Zeitfenstern sensibilisieren.

• Literatur

• 1 Mensink GB, Lampert T, Bergmann E. Übergewicht und Adipositas in Deutschland 1984–2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005; 48: 1348-1356
• 2 Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103: 219-224
• 3 Cedergren MI. Optimal gestational weight gain for body mass index categories. Obstet Gynecol 2007; 110: 759-764
• 4 Plagemann A, Davidowa H, Harder T et al. Developmental programming of the hypothalamus: a matter of insulin. A comment on: Horvath TL, Bruning JC: Developmental programming of the hypothalamus: a matter of fat. Nat Med 2006; 12: 52-53
• 5 Plagemann A, Harder T, Schellong K et al. Fetale Programmierung bei intrauteriner Milieustörung – grundlegende Mechanismen am Beispiel der Körpergewichts- und Stoffwechselregulation. Gynakol Geburtshilfliche Rundsch 2008; 48: 215-224
• 6 Plagemann A, Harder T, Dudenhausen JW. The diabetic pregnancy, macrosomia, and perinatal nutritional programming. Nestle Nutr Workshop Ser Pediatr Program 2008; 61: 91-102
• 7 Haakstad LA, Voldner N, Henrikson T et al. Physical activity level and weight gain in a cohort of pregnant Norwegian women. Acta Obstet Gynecol Scand 2007; 86: 559-564
• 8 Hopkins SA, Cutfield WS. Exercise in pregnancy: weighing up the long-term impact on the next generation. Exerc Sport Sci Rev 2011; 39: 120-127
• 9 Clapp 3rd. JF. Morphometric and neurodevelopmental outcome at age five years of the offspring of women who continued to exercise regularly throughout pregnancy. J Pediatr 1996; 129: 856-863
• 10 Plagemann A, Harder T, Schellong K et al. Fetale Programmierung bei intrauteriner Milieustörung – grundlegende Mechanismen am Beispiel der Körpergewichts- und Stoffwechselregulation. Gynakol Geburtshilfliche Rundsch 2008; 48: 215-224
• 11 Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician / gynecologists should know. Curr Opin Obstet Gynecol 2009; 21: 521-526
• 12 Clapp 3rd JF. Long-term outcome after exercising throughout pregnancy: fitness and cardiovascular risk. Am J Obstet Gynecol 2008; 199: 486-489
• 13 Zavorsky GS, Longo LD. Exercise guidelines in pregnancy: new perspectives. Sports Med 2011; 41: 345-360
• 14 Clapp 3rd JF, Kim H, Burciu B et al. Continuing regular exercise during pregnancy: effect of exercise volume on fetoplacental growth. Am J Obstet Gynecol 2002; 186: 142-147
• 15 Katan MB, Ludwig DS. Extra calories cause weight gain – but how much?. JAMA 2010; 303: 65-66
• 16 Weissgerber TL, Wolfe LA, Davies GA et al. Exercise in the prevention and treatment of maternal-fetal disease: a review of the literature. Appl Physiol Nutr Metab 2006; 31: 661-674
• 17 Korsten-Reck U. Schwangerschaft und Sport, Teil 2: Praktische Empfehlungen für sporttreibende Frauen in Schwangerschaft und Wochenbett. Gynäkologe 2011; 44
• 18 Korsten-Reck U. Schwangerschaft und Sport, Teil 1: Folgen für Mutter und Kind. Gynäkologe 2011; 44: 847-853
• 19 Kurth BM, Schaffrath-Rosario A. Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland (Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KIGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 736-743
• 20 Kromeyer-Hauschild K, Wabitsch M, Kunze D. Perzentile für den Body-Mass-Index für das Kinder- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149
• 21 Arbeitsgemeinschaft Adipositas im Kindes und Jugendalter. Leitlinien, Konsensuskonferenz 2012. 2012. Online: http://www. adipositas-gesellschaft.de/fileadmin/PDF/ Leitlinien/AGA_S2_Leitlinie.pdf Stand 08.05.2014
• 22 Wilmore JH. The application of science to sport: physiological profiles of male and female athletes. Can J Appl Sport Sci 1979; 4: 103-115
• 23 Starker A, Lampert T, Worth A et al. Motorische Leistungsfähigkeit. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 775-783
• 24 Craig MC, Maki PM, Murphy DG. The Women 's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol 2005; 4: 190-194
• 25 Ekström H. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it. Maturitas 2005; 52: 154-164
• 26 Progetto Menopausa Italia Study Group. Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas 2005; 52: 181-189
• 27 Korsten-Reck U, Velde C, Wanke E et al. Postmenopause und Sport. Deutsch Z f Sportmedizin 2013; 6: 167-174
• 28 Zyriax BC, Schoeffauer M, Klipstein-Grobusch K et al. Differential association of anthropometric parameters with coronary risk inwomen – data of the CORA study. Obes Facts 2011; 4: 358-364
• 29 Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002; 81: 603-611
• 30 Klein LC, Corwin EJ, Ceballos RM. Leptin, hunger, and body weight: influence of gender, tobacco smoking, and smoking abstinence. Addict Behav 2004; 29: 921-927
• 31 Kyle UG, Genton L, Hans D et al. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr 2001; 55: 663-672
• 32 Poehlman ET, Goran MI, Gardner AW et al. Determinants of decline in restingmetabolic rate in aging females. Am J Physiol 1993; 264
• 33 Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995; 123: 673-675
• 34 Poehlman ET, Toth MJ, Ades PA et al. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 1997; 27: 322-326
• 35 Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hyper-tension. Arch Intern Med 1989; 149: 1514-1520
• 36 Ravussin E, Klimes I, Sebokova E et al. Lipids and insulin resistance: what we've learned at the Fourth International Smolenice Symposium. Ann N Y Acad Sci 2002; 967
• 37 Haarbo J, Marslew U, Gotfredsen A et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40: 1323-1326
• 38 Nathan DM, Singer DE, Godine JE et al. Noninsulin-dependent diabetes in older patients. Complications and risk factors. Am J Med 1986; 81: 837-842
• 39 Lobo RA. Treatment of postmenopausal Women. Boston: Lippincott; 1999
• 40 Judd HL, Scully RE, Herbst AL et al. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease. Am J Obstet Gynecol 1973; 117: 976-982
• 41 Aloia JF, McGowan DM, Vaswani AN et al. Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 1991; 53: 1378-1383
• 42 Enzi G, Gasparo M, Biondetti PR et al. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986; 44: 739-746
• 43 Willett WC, Manson JE, Stampfer MJ et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 1995; 273: 461-465
• 44 Kemmler W, von Stengel S, Bebenek M et al. Exercise and fractures in postmenopausal women: 12-year results of the Erlangen Fitness and Osteoporosis Prevention Study (EFOPS). Osteoporos Int 2012; 23
• 45 Astrup A. Physical activity and weight gain and fat distribution changes with menopause: current evidence and research issues. Med Sci Sports Exerc 1999; 31 (Suppl. 11)
• 46 World Health Organisation. Obesity: preventing and managing the global epidemic. WHO Report of a WHO Consulting (WHO technical report series 894). 2000